|Calculated MW||9.5 kDa|
|Other Names||PK1, PRK1, Prokineticin 1, EG-VEGF, Endocrine-gland-derived vascular endothelial growth factor, Mambakine|
|Source||Mouse myeloma cell line|
|Application Notes||Reconstitute in sterile PBS to a concentration of 0.1-1.0 mg/ml containing 0.1% BSA. This solution can then be diluted into other aqueous buffers|
|Storage||-20°C; Lyophilized from a 0.2 µm filtered solution in PBS|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Human EG-VEGF (Endocrine-gland-derived Vascular endothelial growth factor) induces proliferation, migration and fenestration in capillary endothelial cells derived from endocrine glands. Recombinant EG-VEGF has a calculated molecular mass of approximately 9.5 kDa protein consisting of 86 amino acid residues.
Li M.,et al.Mol. Pharmacol. 59:692-698(2001).
LeCouter J.,et al.Nature 412:877-884(2001).
Fraser C.,et al.Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
Clark H.F.,et al.Genome Res. 13:2265-2270(2003).
Gregory S.G.,et al.Nature 441:315-321(2006).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.